IRCT20080831001141N33
Recruiting
未知
Comparison of Ovarian Stimulation Cycle Outcome in Medroxy Progesterone Acetate and Gonadotropin Protocol with Antagonist and Gonadotropin Protocol in Polycystic Ovarian Syndrome Patients Undergoing In-Vitro fertilization/ Intracytoplasmic Sperm Injection (IVF/ICSI)
Overview
- Phase
- 未知
- Intervention
- Not specified
- Conditions
- Polycystic ovarian syndrome.
- Sponsor
- Royan Institute
- Enrollment
- 232
- Status
- Recruiting
- Last Updated
- 5 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •The major criteria for diagnosis of PCOS are oligo and/or anovulation, clinical or biochemical signs of hyperandrogenism and polycystic ovaries; these criteria are in accordance with the revised 2003 Rotterdam criteria for PCOS
- •Age between 18 to 39 years
- •Body mass Index (BMI) less than 30 kg/m2
Exclusion Criteria
- •Clinically significant systemic disease such as renal failure
- •Endometriosis grade 3 or higher
- •Received hormonal treatments in the previous 3 months
- •Any contraindications to ovarian stimulation
- •Sever male factor (TESE\-PESA)
Outcomes
Primary Outcomes
Not specified
Similar Trials
Completed
Not Applicable
Comparison of controlled ovarian stimulation with clomiphen citrate HMG(Human menopausal gonadotropin) or clomiphen citrate rFSH(recombinant follicule stimulating hormon) in IUI(Intrauterine Insemination) cycles.Condition 1: Unexplained infertility. Condition 2: Male factor infertility.Female infertility, unspecifiedOligospermia NOSIRCT201109163386N4Semnan University of Medical Sciences142
Completed
Phase 2
Comparison of the Clinical pregnancy outcomes of ovarian stimulation with hMG + rFSH or rFSH + rLH methods in infertile patients.Female infertility associated with anovulation.Female infertility, unspecifiedIRCT2016092720351N3Vice Chancellor or Tehran University of Medical Sciences140
Completed
Phase 2
Assessment the effect of ovarian stimulation with and without letrozole in IVF/ICSI outcomes.IRCT201701291952N8Vice Chancellor for research, Tehran University of Medical Science160
Active, not recruiting
Phase 1
Comparison of the difference in the number of oocytes obtained by administering the ovarian stimulation treatment as usually with administering it only once and later.EUCTR2019-001343-44-ESInstituto Bernabeu180
Completed
Phase 3
Double ovarian stimulation (Shanghai and Duostim protocol)IRCT20080831001141N35Royan Institute100